FDA approves generic version of Cymbalta: 3 things to know

The Food and Drug Administration on Monday approved Solco Healthcare's duloxetine delayed-release capsules.

Here are three things to know.

  1. Duloxetine is used to treat major depressive disorder, general anxiety disorder and fibromyalgia.

  1. The drug represents a generic version of Eli Lilly's Cymbalta.

  1. Both brand name and generic sales of duloxetine hit $484.4 million for the 12 months ending in June 2017, according to data from QuintilesIMS.

More articles on supply chain:

US Bioservices to pay $13.4M to resolve kickback suit
Patients brace for price of 'breakthrough' leukemia drug CTL019
Price of first FDA-approved ALS treatment in 20 years limits patient access at VCU Medical Center

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars